FrancophonIA/ELRC3.0 huggingface dataset:
English: <Aminocaproic acid containing medicinal products>
Maltese: <Prodotti mediċinali li fihom aminocaproic acid>
English: Intense menstruations, menorrhagia and haemorrhagic metropathies.
Maltese: Mestrwazzjonijiet intensi, mestrwazzjoni esaġerata u metropatiji emorraġiċi.
English: • angioneurotic oedema (rapid swelling of the skin, mucosa and submucosal tissues).
Maltese: • edema anġjonewrotika (nefħa mgħaġġla tal-ġilda u tat-tessuti mukużi u sottomukużi).
English: How to store <Aminocaproic acid-containing medicinal products> Contents of the pack and other information
Maltese: Kif taħżen <Prodott mediċinali li fih aminocaproic acid> Kontenut tal-pakkett u informazzjoni oħra
English: Carcinogenesis, mutagenesis and fertility disorders: No long-term studies have been conducted in animals to evaluate the carcinogenic or mutagenic potential of aminocaproic acid.
Maltese: Karċinoġenesi, mutagenesi u disturbi fil-fertilità: ma saru l-ebda studji fit-tul fuq l-annimali biex jevalwaw il-potenzjal karċinoġeniku jew mutaġeniku ta' aminocaproic acid.
English: It is widely distributed (it easily spreads to the tissues, appearing in semen, synovial fluid and foetal tissue) and it is excreted in urine, largely unaltered, with a terminal elimination half life of approximately 2 hours.
Maltese: Jiġi ddistribwit ħafna (jinfirex faċilment fit-tessut, u jidher fis-semen, fil-fluwidu sinovjali u fit- tessut tal-fetu) u jitneħħa fl-awrina, fil-biċċa l-kbira tiegħu mhux mibdul, b'half-life terminali ta' madwar sagħtejn.
English: Very rare (affects less than 1 in 10,000 patients):
Maltese: Rari ħafna (jaffettwaw inqas minn persuna 1 minn kull 10,000):
English: • heart surgery (with or without bypass placement)
Maltese: • operazzjoni tal-qalb (bi jew mingħajr tqegħid ta' bypass)
English: Fertility, pregnancy and breast feeding
Maltese: Fertilità, tqala u treddigħ
English: Clinical presentation can range from mild myalgia with weakness and fatigue to severe proximal myopathy with rhabdomyolysis, myoglobinuria and acute renal failure Muscle enzymes, especially creatine phosphokinase (CPK), are elevated.
Maltese: Il-preżentazzjoni klinika tista' tvarja minn majalġja ħafifa bi dgħufija u għeja kbira, sa mijopatija prossimali severa b'rabdomijolosi, mijoglobinurija u insuffiċjenza akuta tal-kliewi.
English: MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] {Name and address} <{tel}> <{fax}> <{e-mail}>
Maltese: Detentur tal-Awtorizzazzjoni għat-Tqegħid fis-Suq u l-Manifattur [Biex jimtela mill-pajjiż partikolari] [Ara Anness I - Biex timtela mill-pajjiż partikolari] {Isem u indirizz} <{tel}> <{fax}> <{e-mail}>
English: There are no or limited amount of data from the use of epsilon aminocaproic acid in pregnant women.
Maltese: M'hemmx dejta jew hemm dejta limitata dwar l-użu ta' epsilon aminocaproic acid f'nisa tqal.
English: For intravenous administration: 100 mg/kg or 3 g/m2 by slow intravenous infusion during the first hour, followed by continuous infusion at the rate of 33.3 mg/kg per hour or 1 g/m2 per hour.
Maltese: Għall-għoti ġol-vini 100 mg/kg jew 3 g/m2 permezz ta' infużjoni bil-mod ġol-vini matul l-ewwel siegħa, segwita minn infużjoni kontinwa b'rata ta' 33.3 mg/kg kull siegħa jew 1 g/m2 kull siegħa.
English: Aminocaproic acid has been observed to give rise to teratogenic effects in rats.
Maltese: Ġie osservat li aminocaproic acid jikkawża effetti teratoġeniċi fil-firien.
English: Intravenous route: <Aminocaproic acid-containing medicinal products> should be administered in slow intravenous injection with glycated serum, glucosaline or dextrose.
Maltese: Għoti ġol-vini <Prodott mediċinali li fih aminocaproic acid> għandu jingħata permezz ta' injezzjoni bil-mod ġol-vini bi glycated serum, glucosaline jew dextrose.
English: 6.2 Incompatibilities [Invented name] should not be used with levulose solutions, solutions containing penicillin or with blood.
Maltese: .2 Inkompatibbilitajiet [Isem ivvintat] m'għandux jintuża ma' soluzzjonijiet li fihom levulose, soluzzjonijiet li fihom penicillin jew mad-demm.
English: • chest pain or chest tightness
Maltese: • uġigħ fis-sider jew tagħfis fis-sider
English: Angioneurotic oedema
Maltese: F'dan il-fuljett
English: Plasmin can act on other clotting system components such as factors V and VIII and, in particular, fibrinogen.
Maltese: Plasmin jista' jaġixxi fuq komponenti oħrajn ta' sistemi ta' tagħqid tad-demm bħal fatturi V u VIII u, b'mod partikulari, fibrinogen.
English: • hallucinations
Maltese: • aċċessjonijiet
English: • unusual aches or pains in your muscles that go on for longer than you might expect (as these can result in kidney problems and potentially life-threatening muscle damage [rhabdomyolysis])
Maltese: • uġigħ mhux tas-soltu jew uġigħ fil-muskoli li jdum aktar milli tistenna (għax dan jista' jirriżulta fi problemi tal-kliewi u ħsara fil-muskoli [rabdomijolosi] li potenzjalment ikunu ta' periklu għall-ħajja)
English: Pregnancy
Maltese: Trombożi
English: It has been suggested that extravascular clots formed in vivo may not undergo spontaneous lysis like normal clots.
Maltese: Ġie ssuġġerit li emboli extravaskulari li jiffurmaw in vivo jistgħu ma jgħaddux minn lisi spontanja bħal emboli normali.
English: Renal impairment
Maltese: Konġestjoni nażali
English: The literature contains publications about an increased incidence of certain neurological deficits such as hydrocephaly, cerebral ischaemia or cerebral vasospasm associated to the use of antifibrinolytic agents in the treatment of subarachnoid haemorrhage (SAH).
Maltese: Il-letteratura fiha pubblikazzjonijiet dwar żieda fl-inċidenza ta' ċerti nuqqasijiet newroloġiċi bħal idrocefalija, iskemija ċerebrali jew vażospażmu ċerebrali assoċjati mal-użu ta' sustanzi antifibrinolitiċi fil-kura ta' emorraġija subarakinojde (SAH).
English: [If applicable] <[In oral administration, the content of the ampoule can be drunk as it is or mixed with a little sugared water, broth, milk, etc.]>
Maltese: (Jekk applikabbli) <[Fl-għoti mill-ħalq, il-kontenut tal-ampulla jista' jinxtorob kif inhu jew jitħallat ma' ftit ilma bizzokkor, brodu, ħalib, eċċ.]>
English: • odonto-stomatology (dental extractions in haemophiliacs, patients undergoing anticoagulant therapy) Life-threatening haemorrhages induced by thrombolytics (streptokinase, etc.).
Maltese: • odonto-stomatoloġija (qlugħ ta' snien f'persuni emofilijaċi, pazjenti li jkunu taħt kura b'terapija b'mediċini kontra l-koagulazzjoni) Emorraġiji ta' periklu għall-ħajja kkaġunati minn mediċini trombolitiċi (streptokinase, eċċ.). Emorraġiji assoċjati ma' tromboċitopenija, purpura trombopenika, lewkimja.
English: Skeletal muscle effects
Maltese: Effetti fuq il-muskoli skeletriċi
English: Aminocaproic acid is indicated for use in patients of all ages in haemorrhage caused by local or general fibrinolysis, including in Postsurgical haemorrhages in:
Maltese: Aminocaproic acid hu indikat għall-użu f'pazjenti tal-etajiet kollha li jkollhom emorraġija kkawżata minn fibrinolisi lokali jew ġenerali, li tinkludi dik f' Emorraġiji wara operazzjoni fi proċeduri ta':
English: After intravenous administration, tonic-clonic seizures were observed in dogs and mice.
Maltese: Wara l-għoti ġol-vini, aċċessjonijiet toniċi-kloniċi ġew osservati fil-klieb u filġrieden.
English: Other side effects are:
Maltese: Minn ġol-vini:
English: Elevated CPK, myositis
Maltese: Dgħufija filmuskoli, mijalġja
English: • bleeding associated with thrombocytopenia (low platelets), thrombocytopenic purpura (bleeding disorder that affects the small vessels) or leukaemia;
Maltese: • ħruġ ta' demm assoċjat ma' tromboċitopenija (għadd baxx ta' plejtlits), purpura tromboċitopenika (disturb ta' ħruġ ta' demm li jaffettwa l-vini ż-żgħar) jew lewkimja;
English: WHAT Aminocaproic acid containing medicinal product IS AND WHAT IT IS USED FOR <Aminocaproic acid-containing medicinal products>belongs to a group of medicines called antifibrinolytics, i.e. drugs to prevent blood loss (haemorrhage).
Maltese: <Prodott mediċinali li fih aminocaproic acid> jappartjenu għal grupp ta' mediċini msejħa antifibrinolitiċi, i.e. mediċini għall-prevenzjoni ta' telf ta' demm (emorraġija).
English: Aminocaproic acid has an inhibitor effect on this system, which takes place on two levels: on the one hand, at relatively low concentrations, it inhibits the action of plasminogen activators by a competitive mechanism; on the other, at higher concentrations it inhibits plasmin activity.
Maltese: Aminocaproic acid għandu effett ta' inibitur fuq din is-sistema, li sseħħ fuq żewġ livelli: l-ewwel wieħed f'konċentrazzjonijiet relattivament baxxi jinibixxi l-azzjoni tal-attivaturi ta' plasminogen permezz ta' mekkaniżmu kompetittiv; u t-tieni, f'konċentrazzjonijiet ogħla jinibixxi l-attività ta' plasmin.
English: If you use more <Aminocaproic acid-containing medicinal products> than you should If you take more <Aminocaproic acid-containing medicinal products> than you should, you may experience a sudden decrease in blood pressure (hypotension), with symptoms including dizziness, fainting, lightheadedness, blurred vision, a rapid, or irregular heartbeat (palpitations), confusion, feeling like you are going to be sick (nausea) or general weakness.
Maltese: Jekk tieħu <Prodott mediċinali li fih aminocaproic acid> aktar milli suppost Jekk tieħu iktar <Prodott mediċinali li fih aminocaproic acid> milli suppost, jista' jkollok tnaqqis f'daqqa tal-pressjoni tad-demm (pressjoni baxxa), b'sintomi li jinkludu sturdament, ħass ħażin, mejt, vista mċajpra, taħbit tal-qalb mgħaġġel jew irregolari (palpitazzjonijiet), konfużjoni, tħossok imdardar (nawsja) jew ikollok dgħufija ġenerali.
English: • obstetrics (post-partum and post-miscarriage haemorrhages) after correction of the coagulation defect
Maltese: • ostetrija (emorraġiji wara l-ħlas u wara korriment) wara korrezzjoni ta' difett talkoagulazzjoni
English: Maculopapular erythema
Maltese: Il-pazjent irċieva
English: vomiting, dizziness, pins and needles, loss of concentration
Maltese: Insuffiċjenza talkliewi, żieda filBUN, koliċi nefrotiċi u disturbi filfunzjoni talkliewi
English: * frequency not known (cannot be estimated from the available data).
Maltese: * frekwenza mhux magħrufa (ma tistax tittieħed stima mid-data disponibbli).
English: • delirium
Maltese: • rimettar
English: <Aminocaproic acid-containing medicinal products> is used to prevent blood loss due to excessive bleeding in patients of all ages.
Maltese: <Prodott mediċinali li fih aminocaproic acid> jintużaw għall-prevenzjoni ta' telf eċċessiv ta' demm f'pazjenti ta' kull età.
English: In fact, the appearance or persistence of a haemorrhage could be, and in many cases is, due to local hyperfibrinolysis, especially when the haemorrhage is in organs rich in plasminogen activators, such as the uterus, prostate, lung, urinary tract, etc. On the other hand, aminocaproic acid has been shown to have a beneficial effect on general haemorrhages, such as those of a haematological origin, in which no hyperfibrinolysis is found in circulating blood.
Maltese: Fil-fatt, id-dehra jew il-persistenza ta' emorraġija tista' tkun, u f'ħafna każijiet hi dovuta, għal iperfibrinolisi lokali, speċjalment meta lemorraġija tkun f'organi li huma rikki f'attivaturi ta' plasminogen, bħall-utru, il-prostata, il-pulmun, l-apparat tal-awrina, eċċ.
English: Breastfeeding
Maltese: Sturdament
English: Therapeutic indications
Maltese: TAL-PRODOTT MEDIĊINALI
English: This drug must not be administered without a definitive diagnosis and/or laboratory findings indicating hyperfibrinolysis (hyperplasminaemia).
Maltese: Din il-mediċina m'għandhiex tingħata mingħajr dijanjosi definittiva u/jew riżultati tallaboratorju li jindikaw iperfibrinolisi (iperplażminemija).
English: • kidney failure
Maltese: • konġestjoni nażali
English: Pharmacokinetic properties
Maltese: Tagħrif farmakokinetiku
English: The administration of the equivalent to the maximum therapeutic dose in humans in the diet of rats caused fertility disorders in both sexes.
Maltese: L-għoti tal-ekwivalenti għad-doża massima terapewtika fil-bnedmin fid-dieta tal-firien ikkawża disturbi fil-fertilità taż-żewġ sessi.
English: The clinical relevance of these findings is unknown (see section 5.3).
Maltese: Ir-rilevanza klinika ta' dawn ir-riżultati mhijiex magħrufa (ara sezzjoni 5.3).
English: [See Annex I - To be completed nationally] This leaflet was last revised in <{MM/YYYY}> <{month YYYY}>.
Maltese: [Jekk [applikabbli] <jista' jingħata [jew mill-ħalq jew] minn ġol-vini, u>
English: Aminocaproic acid should not be used when there is evidence of an active intravascular clotting process (see section 4.4).
Maltese: Aminocaproic acid m'għandux jintuża meta jkun hemm evidenza ta' proċess attiv ta' tagħqid ta' demm intravaskulari (ara sezzjoni 4.4).
English: Thrombogenic effect
Maltese: Effett tromboġeniku
English: Intravenous route: The desired blood level is reached with an initial dose of 4 to 5 g by slow intravenous infusion (over one hour), followed by a continuous infusion of 1 g/hour.
Maltese: Għall-għoti ġol-vini: se tingħata doża inizjali ta' 4 sa 5 g permezz ta' infużjoni bil-mod (ta' siegħa) ġol-vini segwita minn infużjoni kontinwa ta' 1 g kull siegħa.
English: Unknown frequency:
Maltese: Informazzjoni għall-pazjent
English: Abdominal pain, diarrhoea, nausea, vomiting
Maltese: Uġigħ addominali, dijarea, dardir, rimettar
English: Serious cases of myopathy and rhabdomyolysis have been reported; these are generally reversible of discontinuation of treatment but CPK must be monitored in patients undergoing prolonged treatment and treatment stopped if any elevation in CPK occurs.
Maltese: Minflok, jidher li dan it-tagħqid ta' demm intravaskulari kien probabbilment ikkawżat minn kundizzjoni klinika li kienet teżisti minn qabel, i.e. il-preżenza ta' DIC.
English: HOW TO USE <Aminocaproic acid-containing medicinal products>
Maltese: Qabel ma tuża <Prodott mediċinali li fih aminocaproic acid>
English: Hypotension Bradycardia
Maltese: Indikazzjonijiet terapewtiċi
English: Bottle (HDPE) 90 (3 x 30) tablets
Maltese: 90 (3 x 30) pillola
English: MA (EU) number (Invented) name
Maltese: Numru ta' l-EU Numru tal-MA
English: Bottle (HDPE) 30 tablets
Maltese: 30 pillola
English: See also Section 12.
Maltese: Ara wkoll Sezzjoni 12.
English: Dechra Veterinary Products Srl Via Agostino da Montefetro 2 10134 Torino
Maltese: Dechra Veterinary Products Srl Via Agostino da Montefetro 2 10134
English: Locomotor disorders:
Maltese: Disturbi lokomotorji:
English: Dechra Veterinary Products Sp. z o.o.
Maltese: Dechra Veterinary Products Sp. z o.o. ul.
English: 5 days
Maltese: 5 ijiem
English: ATCvet code: QM01AC06
Maltese: Kodici ATC veterinarja: QM01AC06.
English: Multi-packs of 5 x 20 ml and 10 x 20 ml.
Maltese: Pakketti multipli ta' 5 x 20 ml u 10 x 20 ml.
English: Meloxicam is predominantly found in plasma.
Maltese: Meloxicam jinstab predominantement fil-plażma.
English: Date of first authorisation: 22/04/2013 Date of last renewal: 20/04/2018
Maltese: Data tal-aħħar tiġdid: 20/04/2018
English: Batch {number}
Maltese: Lott {numru}
English: Disodium edetate Sodium hydroxide Hydrochloric acid Meglumine Water for injections
Maltese: Disodium edetate Sodium hydroxide Hydrochloric acid Meglumine Ilma għall-injezzjoni
English: The active substance in Meloxidolor is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Maltese: Is-sustanza attiva f'Meloxidolor hija sustanza ammissibbli kif deskritt fit-tabella numru 1 fl-anness tarRegolament tal-Kummissjoni (UE) Nru 37/2010:
English: Pharmacologically active substance
Maltese: Sustanza farmakoloġikament attiva
English: Multi-pack of 12 x 100ml
Maltese: Multi-pakkett ta '12 x 100ml
English: Excipient: Ethanol 150 mg
Maltese: Ethanol 150 mg
English: Meloxicam Meloxicam Bovine, caprine, porcine, rabbit,
Maltese: Meloxicam Meloxicam Gniedes, mogħoż, qżieżeż, fniek,
English: Dechra Veterinary Products S.L.U.
Maltese: Dechra Veterinary Products S.
English: Sodium hydroxide Hydrochloric acid Glycofurol Meglumine Water for injections
Maltese: Sodium hydroxide Hydrochloric acid Glycofurol Meglumine Ilma għall-injezzjoni
English: In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Maltese: Studji in vivo u in vitro urew li Meloxicam jinibixxi cyclooxygenase-2 (COX-2) b'mod iktar qawwi minn cyclooxygenase-1 (COX-1).
English: 4941 SJ Raamsdonksveer The Netherlands
Maltese: 4941 VX Raamsdonksveer The Netherlands
English: Cats: SC
Maltese: SC
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Maltese: Il-frekwenza ta' effetti mhux mixtieqa hija definita skont din il-konvenzjoni: - komuni ħafna (aktar minn wieħed f'10 annimali li juru effetti mhux mixtieqa matul il-perjodu ta' kura waħda) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal) - rari (aktar minn wieħed iżda inqas minn10 annimali f'10,000 annimal) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal, inklużi rapporti iżolati).
English: 3421 TV Oudewater The Netherlands
Maltese: 3421 TV Oudewater
English: For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritisagalactia syndrome) with appropriate antibiotic therapy.
Maltese: Għal terapija addizzjonali fit-trattament ta' settiċemija puwerperali u tossemija (sindrome mastitemetrite-agalaktja) flimkien ma' terapija antibijotika adattata.
English: Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Maltese: NSAIDs oħrajn, dijuretiċi, antikoagulanti, antibijotiċi aminoglycoside u sustanzi oħra li jeħlu ħafna mal-proteini, jistgħu jikkompetu għat-twaħħil u b'hekk iwasslu għal effetti tossiċi.
English: Republika Hrvatska Genera Inc.
Maltese: Genera Inc.
English: Dogs: IV or SC
Maltese: SC, IV Majjali: IM Klieb: IV jew SC
English: More than 98 % of meloxicam is bound to plasma proteins.
Maltese: Iktar minn 98% ta' meloxicam jeħel mal-proteini tal-plażma.
English: MRL Target tissues
Maltese: MRL Tessuti mmirati
English: 3421 TV Oudewater The Netherlands Tel: +31 (0)348 565858
Maltese: 3421 TV Oudewater Il-Pajjiżi l-Baxxi Tel: +31 (0)348 565858
English: More than 97 % of meloxicam is bound to plasma proteins.
Maltese: Iktar minn 97% ta' meloxicam jeħel mal-proteini tal-plażma.
English: Musculo-skeletal disorders:
Maltese: Mard muskolu-skeletriku:
English: Hintere Achmühlerstraße 1A A - 6850 Dornbirn Tel. +55 72 402 42 55
Maltese: Hintere Achmühlerstraße 1A A - 6850
English: 21 % of the recovered dose is eliminated in urine (2 % as unchanged meloxicam, 19 % as metabolites) and 79 % in the faeces (49 % as unchanged meloxicam, 30 % as metabolites).
Maltese: Fil-qtates, l-osservazzjoni ta' metaboliti mill-kompost prinċipali fl-awrina u l-ippurgar, iżda mhux filplażma, hi indikattiva għat-tneħħija mgħaġġla tagħhom. 21% tad-doża rkuprata titneħħa fl-awrina (2% bħala meloxicam mhux mibdul, 19% bħala metaboliti) u 79% fl-ippurgar (49% bħala meloxicam mhux mibdul, 30% bħala metaboliti).
English: ul.
Maltese: IV.
English: 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Maltese: Doża eċċessiva (sintomi, proċeduri ta' emerġenza, antidoti):
English: Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects.
Maltese: Meloxicam hu Mediċina Mhux Sterojdi Kontra l-Infjammazzjoni (NSAID) tal-klassi oxicam li taġixxi bl-inibizzjoni tas-sintesi ta' prostaglandin, u b'hekk teżerċita effetti anti-infjammatorji, kontra ttnixxija, analġesiċi u antipiretiċi.
English: Name and address of the manufacturer responsible for batch release Produlab Pharma B.V.
Maltese: Manifattur responsabbli mill-ħruġ tal-lott Produlab Pharma B.V.
English: Package (size)
Maltese: Pakkett (daqs)
English: Manufacturer for the batch release: Produlab Pharma B.V.
Maltese: Produlab Pharma B.V.
English: Therapeutic classification
Maltese: Klassifikazzjoni terapewtika
English: Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids (oxicams).
Maltese: Prodotti anti-infjammatorji u antirewmatiċi, mhux sterojdi (oxicams)
English: The excipients listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Maltese: L-eċċipjenti elenkati f'sezzjoni 6.1 tal-karatteristiċi tal-prodott fil-qosor huma jew sustanzi ammissibbli li għalihom m'hemmx bżonn ta' MRLs kif indikat fit-tabella 1 tal-anness għarRegolament tal-Kummissjoni (UE) Nru 37/2010 jew huma kkunsidrati li ma jaqgħux fl-ambitu tarRegolament (KE) Nru 470/2009 meta użati bħal f'dan il-prodott mediċinali veterinarju.
English: NO ENTRY
Maltese: L-EBDA ENTRATA
English: EXP {month/year} Once broached, use by ….
Maltese: JIS {xahar/sena} Ladarba jittaqqab, uża sa ....
English: After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmax values of 2.1 µg/ml and 2.7 µg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Maltese: Wara l-għoti ta' doża waħda taħt il-ġilda ta' 0.5 mg ta' meloxicam/kg, intlaħqu valuri Cmax ta' 2.1 µg/ml u 2.7 µg/ml wara 7.7 sigħat u 4 sigħat f'baqar żgħar u f'baqar li jkunu qed ireddgħu, rispettivament.
English: In dogs and cats, Meloxicam is eliminated with a half-life of 24 hours.
Maltese: Fil-klieb u l-qtates, Meloxicam jiġi eliminat b'half-life ta' 24 siegħa.
English: Meloxicam is eliminated with a half-life of 26 hours after subcutaneous injection in young cattle.
Maltese: Meloxicam jiġi eliminat b'half-life ta' 26 siegħa wara injezzjoni taħt il-ġilda f'baqar żgħar.
English: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Maltese: Fin-nuqqas ta' studji dwar kompatibilità, dan il-prodott mediċinali veterinarju ma jistax jintuża flimkien ma' prodotti mediċinali veterinarji oħra.
English: For the relief of post-operative pain associated with minor soft tissue surgery such as castration.
Maltese: Għas-serħan minn uġigħ post-operattiv assoċjat ma' kirurġija minuri tat-tessut artab bħal kastrazzjoni.
English: Carton for 50 ml and 100 ml
Maltese: Kartuna għal 50 ml u 100 ml
English: In very rare cases, haemorrhagic diarrhoea, haematemesis and gastrointestinal ulceration have been reported.
Maltese: F'każijiet rari ħafna, dijarea emorraġika, ematemesi u ulċerazzjoni gastrointestinali ġew irrappurtati.
English: Active substance: Meloxicam 20 mg
Maltese: Meloxicam 20 mg
English: Meat and offal: 5 days
Maltese: laħam u ġewwieni tal-annimali: 5 ijiem
English: Following subcutaneous administration, meloxicam is completely bioavailable and maximal mean plasma concentrations of 0.73 g/ml in dogs and 1.1 µg/ml in cats were reached approximately 2.5 hours and 1.5 hours post administration, respectively.
Maltese: Wara l-għoti taħt il-ġilda, meloxicam hu kompletament bijodisponibbli, u l-ogħla medja ta' konċentrazzjonijiet fil-plażma ta' 0.73 g/ml, fil-klieb u 1.1 g/ml fil-qtates intlaħqu wara madwar 2.5 sigħat u 1.5 sigħat wara l-għoti rispettivament.
English: Dogs, cats, cattle (calves) and pigs
Maltese: Klieb, qtates, baqar (għoġġiela) u majjali